Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma

Trial ID or NCT#

NCT00767936

Status

not recruiting iconNOT RECRUITING

Purpose

Adult liver cancer is the third leading cause of cancer deaths worldwide. The major risk factor for liver cancer is hepatitis B virus (HBV) infection. The purpose of the study is to sequence the HBV genome in patients with chronic HBV infection, and in patients with liver cancer resulting from chronic HBV infection. The goal is to identify mutations in the HBV genome that predisposes these high risk individuals to the development of liver cancer.

Official Title

Viral and Host Factors Associated With Development of Hepatitis B Virus-related Hepatocellular Carcinoma

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: Male
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. 1. Patients diagnosed with liver cancer based on biopsy or serum AFP level, associated with characteristic hypervascular liver tumors on triphasic spiral CT scan or MRI. 2. Patients with non-cancer liver conditions such as cirrhosis, adenoma, cholangioma, or nodular hyperplasia. 3. Patients with hepatitis B or hepatitis C viral infections not associated with liver cancer.
Exclusion Criteria:
  1. No other patients except those listed above will be recruited. Additionally, patients will be excluded if, upon looking through their medical records, information required for data analysis are missing.
View All Criteria
Show Less

Investigator(s)

Samuel So, MD
Samuel So, MD
Surgical oncologist, Liver surgeon, General surgeon
Lui Hac Minh Professor in the School of Medicine

Contact us to find out if this trial is right for you.

Contact

ccto-office@stanford.edu
650-498-7061

View on ClinicalTrials.gov